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A b s t r a c t
Background: The growing penetration of mechanical reperfusion in ST-elevation myocardial infarction (STEMI) has been 
achieved by the creation of new percutaneous coronary intervention (PCI) centres which have helped to shorten delays but 
have compromised PCI volumes. 
Aim: To compare the outcomes in STEMI patients treated in PCI centres with or without surgical back-up. 
Methods: Data concerning 1,650 registry patients was analysed. The analysis was based on cathlab classification with cardiac 
surgery on site (n = 996) and without (n = 654).
Results: There was a 0.3% rate of transfer (two patients out of 654) for urgent coronary artery bypass grafting from PCI centres 
without cardiac surgery on site. There were no differences in in-hospital and long-term mortality in patients in both studied groups.   
Conclusions: No differences in short and long-term outcomes were noticed for STEMI patients treated in centres with or 
without cardiac surgery on-site. 
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INTRODUCTION
The introduction of primary percutaneous coronary inter-
vention (PCI) by the European Society of Cardiology (ESC) 
guidelines as the treatment of choice for ST-elevation myo-
cardial infarction (STEMI) eligible patients (class IA) has led 
to the dynamic evolution of PCI centres in most European 
countries [1]. The growing penetration of mechanical rep-
erfusion in STEMI, reaching over 80–90% in some regions 
in Europe, has been achieved by the creation of new PCI 
centres, including in rural areas far from large academic 
teaching hospitals. This has helped shorten delays, but at 
the same time it has compromised PCI volumes performed 
at such centres [2]. Doubts have been raised, supported by 
clinical data, that an uncontrolled spread of PCI capable 
hospitals may adversely impact not only the quality of care, 
but also survival [3–5]. Additional voices have also spoken 
against the separation of PCI in acute myocardial infarction 
from surgical on-site back-up [5, 6].
Our aim was to analyse the real life registry data from the 
EUROTRANSFER database in order to compare outcomes in 
STEMI patients treated in PCI centres with or without surgi-
cal back-up.
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METHODS
The current patient and invasive cardiology centre (cathlab) 
analysis was based on the EUROTRANSFER Registry data 
(ClinicalTrials.gov NCT00378391), the main results of which 
have already been published [7, 8]. The registry database of 
1,650 patients enrolled between 2005 and 2007 in 15 cath-
eterisation laboratories in seven European countries (Poland, 
Sweden, Germany, Italy, Spain, Finland, and Slovenia) was 
researched. The study protocol complied with the Declaration 
of Helsinki and was approved by the Jagiellonian University 
Bioethics Committee in Krakow, Poland. 
The primary analysis in this paper was based on the pres-
ence or absence of on-site (within one hospital area) cardiac 
surgery affiliated to the cathlab.
The primary end-points of this analysis were in-hospital, 
30-day and one-year all-cause mortality. Additional end-points 
included all-cause death and non-fatal re-infarction and ad-
ditional urgent revascularisation (PCI or coronary artery bypass 
graft [CABG]) during the 30-day observation period. PCI gen-
eral complications and bleeding events such as puncture site 
haematomas and major bleedings requiring blood transfusion 
(at least one pack of blood cells) were also assessed. 
Statistical methods
Data was analysed according to the established statistical 
protocols. Results were presented as percentages of pa-
tients or means (± standard deviation) where applicable. 
Differences between groups were tested using c2 test and 
Mann-Whitney U test for continuous variables. Kaplan-Meier 
survival curve was plotted for one-year survival and compared 
using log-rank test. All tests were two tailed and a p value of 
less than 0.05 was considered to be statistically significant. 
Statistical analyses were performed using SPSS 20 (SPSS Inc., 
Chicago, IL, USA).
RESULTS
There were 996 (60%) patients who were admitted to PCI 
centres with cardiac surgery on-site and 654 (40%) patients 
admitted to cathlabs with no cardiac surgery on-site. Base-
line characteristics and clinical status on admission, as well 
as procedural details of angiography and PCI, were similar 
in both groups (Table 1). There was a 0.3% rate of transfer 
(two patients of 654) for urgent CABG from a PCI centre 
without cardiac surgery on site. There were no differences in 
in-hospital and long-term mortality in patients in both stud-
ied groups. Comparable one-year mortality in those patients 
who required immediate bypass surgery (CABG) was found 
in hospitals with and without cardiac surgery on-site (Table 2, 
Fig. 1). Of 15 participating centres, seven (47%) were high 
primary PCI centres (> 300 PPCI per year), and eight (53%) 
were moderately low primary PCI centres (< 300 PPCI per 
year). On-site cardiac surgery was available for four (57%) 
high volume PPCI centres and for four (50%) low volume PPCI 
centres (p > 0.05). The in-hospital and one year mortality 
of STEMI patients did not differ in low vs. high PPCI volume 
centres in our study (7.6% vs. 8.9%, p = 0.417).
DISCUSSION
The rapid expansion of PCI procedures for acute myocardial 
infarction in Europe over the past decade has led to an enor-
mously high penetration of PPCI services in countries like Ger-
many, Switzerland, Poland, Sweden and the Czech Republic 
[2]. The launching of more and more catheterisation labs, not 
only in academic centres and not always with on-site surgi-
cal back-up, has resulted in reasonable doubts as to whether 
the safety of patients in terms of clinical and periprocedural 
outcomes will remain secure in a low volume setting and in 
those without on-site surgery [3]. Historical data from Wenn-
berg et al. [5] showed a significant mortality benefit if PCI was 
Table 1. Demographics and angiography divided by on-site cardiac surgery
On-site (n = 996) None (n = 654) P
Age 63.7 ± 12.5 64.5 ± 11.9 0.184
Sex [males] 73% (727) 71% (464) 0.481
Previous myocardial infarction 11.5% (114) 14% (92) 0.079
Smoking habit 36.5% (363) 35.5% (232) 0.735
Diabetes mellitus 15% (149) 18% (118) 0.125
Previous PCI 7% (70) 8% (52) 0.435
Killip 3+4 on admission 5.9% (59) 4.6% (30) 0.277
Radial access 20% (199) 3.5% (23) 0.001
TIMI 3 in baseline angiography 14% (139) 13% (85) 0.701
TIMI 3 post PCI 96% (956) 95% (621) 0.319
PCI — percutaneous coronary intervention; TIMI — Thrombolysis in Myocardial Infarction
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performed in hospital with surgical back up. In 2001, the 
American College of Cardiology/American Heart Association 
issued a class III recommendation for performing angioplasty 
in centres with no surgery on-site [6]. Real life has verified 
these recommendations and alarmist voices have turned out 
to be at least exaggerated in terms of the high demand for life 
and quality of life saving procedures like PCIs. Current ESC 
guidelines recommend that minimal minimum of 0.3 million 
inhabitants should comprise one PCI centre [1]. 
Some more recent papers have indicated that it is 
a well-organised high volume system that influences the 
outcome most, not factors concerning the operators, and 
the experience of the whole team plays a major role [9, 10]. 
A study by Wharton et al. [11] goes further, concluding that 
the transfer of high risk acute myocardial infarction patients to 
hospitals with surgical back-up postpones reperfusion by more 
than 60 min, provides similar safety, and a 30-day death rate 
of 8.5% compared to 3.4% (p = 0.054) in patients treated in 
PCI centres without surgery on-site. 
The most striking finding in the EUROTRANSFER Reg-
istry data, however, is the scarce need for urgent CABG in 
patients treated in hospitals with no on-site cardiac surgery 
(ca. 0.3%). This translates to one patient a year who needs to 
be dispatched for surgery in a centre with 300 PPCI per year. 
Does this justify the need for on-site surgery if the outcome is 
the same? It also seems that the presence of surgeons on-site 
makes invasive cardiologists more inclined to send their pa-
tients to their colleagues (0.3% vs. 1.3%, p = 0.059), while 
the outcome of patients treated by cardiac surgeons is fairly 
low in both situations (mainly due to poorer baseline clinical 
Table 2. Primary percutaneous coronary intervention (PCI) outcome and complications divided by on-site cardiac surgery
On-site (n = 996) None (n = 654) P
Ischaemic complications
Death in-hospital 3.8% (38) 4.1% (27) 0.796
Death at 30 days 5.3% (53) 5.4% (35) 0.979
Death+reMI+rev at 30 days 8.4% (84) 6.6% (43) 0.186 
Death at one year 8.4% (84) 8.3% (54) 0.899
Urgent CABG in-hospital 1.3% (13) 0.3% (2) 0.059
One-year death 30.8% (4) 50% (1) 0.931
Urgent PCI in-hospital 1.7% (17) 0.9% (6) 0.204
Bleeding in-hospital
Intracranial haemorrhage 0% (0) 0% (0) –
Puncture site haematoma 7.5% (75) 4.0% (26) 0.003
Blood transfusion 2.0% (20) 1.1% (7) 0.167
Time delays
Admission to balloon [min] 36 ± 24 34 ± 24 0.690
PCI complications
No-reflow 3.2% (32) 2.8% (18) 0.661
Distal embolisation 1.6% (16) 2.4% (16) 0.274
Perforation 0.2% (2) 0% (0) 0.521
Tamponade 0.2% (2) 0% (0) 0.373
Side branch occlusion 1% (10) 0% (0) 0.008
reMI — repeat myocardial infarction; rev — revascularisation; CABG — coronary artery bypass grafting
Figure 1. Kaplan-Meier survival curves for patients treated in 
invasive cardiology centres without cardiac surgery on-site (fine 
line) and with cardiac surgery on-site (dotted line). Statistically 
non-significant p = 0.799 (log-rank test)
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characteristic of patients). High volume PPCI centres with 
cardiac surgery on-site are becoming a rarer commodity as 
more cathlabs are launched every year. We believe that our 
results support the role and safety of PCI centres who work 
on a daily basis without surgical back up on-site. In our study, 
we observed more frequent access site bleeding complica-
tions in a group of patients treated in cathlabs with on-site 
surgery. These have not, however, triggered major bleeding 
complications requiring transfusions which were equally dis-
tributed between the groups. The outcome may result from 
factors the influence of which was not recorded in this study.
The EUROTRANSFER registry was performed in 15 inva-
sive cardiology centres in Europe and may thus reflect only 
the situation in these centres and regions of Europe. 
CONCLUSIONS
No differences in short and long-term outcome were noticed 
for STEMI patients treated in centres with or without cardiac 
surgery on-site. 
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S t r e s z c z e n i e
Wstęp: Coraz większy odsetek chorych z zawałem serca z uniesieniem odcinka ST (STEMI) leczonych metodami przezskórnej 
angioplastyki wieńcowej (PCI) został osiągnięty poprzez tworzenie nowych pracowni kardiologii inwazyjnej, co pozwoliło 
skrócić czas do uzyskania docelowej terapii.
Cel: Celem pracy było porównanie rokowania pacjentów z STEMI leczonych PCI w ośrodkach z bezpośrednim zabezpie-
czeniem kardiochirurgicznym i bez niego.
Metody: Zebrano dane dotyczące 1650 pacjentów. Spośród nich 996 było leczonych w pracowniach kardiologii inwazyjnej 
z zabezpieczeniem kardiochirurgicznym na miejscu, a 654 bez bezpośredniego zabezpieczenia kardiochirurgicznego.
Wyniki: W grupie pacjentów z pracowni bez oddziału kardiochirurgii na miejscu tylko 0,3% osób z STEMI (2 chorych z 654) 
zostało przekazanych do pilnej operacji pomostowania aortalno-wieńcowego. Nie zaobserwowano różnic w śmiertelności 
odległej w obu porównywanych grupach w 12. miesiącu po PCI.
Wnioski: Obecność oddziału kardiochirurgii na miejscu nie jest wymogiem koniecznym do prowadzenia interwencyjnego 
leczenia zawału serca w pracowniach kardiologii inwazyjnej i nie wiąże się z lepszymi odległymi wynikami klinicznymi.
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